Molecular Partners Ag (MOLN) Return on Assets (2021 - 2026)
Molecular Partners Ag (MOLN) posted quarterly Return on Assets of 14.62% for Q1 2026, down 1462.0% year-on-year from 1.07% in Q1 2025, and down 25.21% on a QoQ basis from 11.67% in Q4 2025.
Molecular Partners Ag (MOLN) Return on Assets (2021 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Return on Assets for 6 consecutive years, with 14.62% the latest figure, recorded in Q1 2026.
- Quarterly Return on Assets fell 1462.0% year-over-year to 14.62% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 14.62% (down 1462.0% YoY) and the FY2025 annual result came in at 0.01%, down 1.0% from the prior year.
- Return on Assets retreated to 14.62% in Q1 2026 per MOLN's latest filing, from 11.67% in the prior quarter.
- Over the last five years, Return on Assets for MOLN reached as high as 0.0% in Q1 2023 and fell as low as 14.62% in Q1 2026.
- A 5-year average of 2.07% and a median of 0.0% in 2024 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2022 — Return on Assets changed 0 bps — and 2026, when it tumbled 1462 bps.
- Year by year, Return on Assets stood at 0.0% in 2022, then tumbled by 186 bps to 0.0% in 2023, then rose by 4 bps to 0.0% in 2024, then plunged by 167027647 bps to 11.67% in 2025, then retreated by 25 bps to 14.62% in 2026.
- According to Business Quant data, Return on Assets over the past three periods registered 14.62%, 11.67%, and 8.87% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.69% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.01% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -0.80% |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 0.00% |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - | -14.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.62% |
| Dec 31, 2025 | -11.67% |
| Sep 30, 2025 | -8.87% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |